These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23538177)

  • 1. Evaluating the impact of unmeasured confounding with internal validation data: an example cost evaluation in type 2 diabetes.
    Faries D; Peng X; Pawaskar M; Price K; Stamey JD; Seaman JW
    Value Health; 2013; 16(2):259-66. PubMed ID: 23538177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchical priors for bias parameters in Bayesian sensitivity analysis for unmeasured confounding.
    McCandless LC; Gustafson P; Levy AR; Richardson S
    Stat Med; 2012 Feb; 31(4):383-96. PubMed ID: 22253142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian sensitivity analysis for unmeasured confounding in observational studies.
    McCandless LC; Gustafson P; Levy A
    Stat Med; 2007 May; 26(11):2331-47. PubMed ID: 16998821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.
    Tunceli O; Wade R; Gu T; Bouchard JR; Aagren M; Luo W
    Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "A Bayesian sensitivity analysis to evaluate the impact of unmeasured confounding with external data: a real world comparative effectiveness study in osteoporosis".
    Zhang X; Faries DE; Boytsov N; Stamey JD; Seaman JW
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):982-92. PubMed ID: 27396534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage of routinely collected oncology clinical data with health insurance claims data--an example with aromatase inhibitors, tamoxifen, and all-cause mortality.
    Dore DD; Liang C; Ziyadeh N; Norman H; Bayliss M; Seeger JD
    Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2():29-36. PubMed ID: 22552977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Martingale residual-based method to control for confounders measured only in a validation sample in time-to-event analysis.
    Burne RM; Abrahamowicz M
    Stat Med; 2016 Nov; 35(25):4588-4606. PubMed ID: 27306611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian modeling of cost-effectiveness studies with unmeasured confounding: a simulation study.
    Stamey JD; Beavers DP; Faries D; Price KL; Seaman JW
    Pharm Stat; 2014; 13(1):94-100. PubMed ID: 24446072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sensitivity analysis using information about measured confounders yielded improved uncertainty assessments for unmeasured confounding.
    McCandless LC; Gustafson P; Levy AR
    J Clin Epidemiol; 2008 Mar; 61(3):247-55. PubMed ID: 18226747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjustment for unmeasured confounding through informative priors for the confounder-outcome relation.
    Groenwold RHH; Shofty I; Miočević M; van Smeden M; Klugkist I
    BMC Med Res Methodol; 2018 Dec; 18(1):174. PubMed ID: 30577773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis.
    Pelletier EM; Pawaskar M; Smith PJ; Best JH; Chapman RH
    J Med Econ; 2012; 15(6):1039-50. PubMed ID: 22533526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods to assess intended effects of drug treatment in observational studies are reviewed.
    Klungel OH; Martens EP; Psaty BM; Grobbee DE; Sullivan SD; Stricker BH; Leufkens HG; de Boer A
    J Clin Epidemiol; 2004 Dec; 57(12):1223-31. PubMed ID: 15617947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the impact of confounding (measured and unmeasured) in a case-control study to examine the increased risk of pandemic A/H1N1 associated with receipt of the 2008-9 seasonal influenza vaccine.
    Rosella LC; Groenwold RH; Crowcroft NS
    Vaccine; 2011 Nov; 29(49):9194-200. PubMed ID: 22001885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of statin plus fibrate combination therapy and statin monotherapy in patients with type 2 diabetes: use of propensity-score and instrumental variable methods to adjust for treatment-selection bias.
    Suh HS; Hay JW; Johnson KA; Doctor JN
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):470-84. PubMed ID: 22461130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian modelling of lung cancer risk and bitumen fume exposure adjusted for unmeasured confounding by smoking.
    de Vocht F; Kromhout H; Ferro G; Boffetta P; Burstyn I
    Occup Environ Med; 2009 Aug; 66(8):502-8. PubMed ID: 19060029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of observational studies with unmeasured confounders.
    McCandless LC
    Int J Biostat; 2012 Jan; 8(2):. PubMed ID: 22499731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular event costs in patients with Type 2 diabetes mellitus.
    Johnston SS; Sheehan JJ; Shah M; Cappell K; Princic N; Smith D; Kalsekar I
    J Med Econ; 2015; 18(12):1032-40. PubMed ID: 26189723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US.
    St Charles M; Minshall ME; Pandya BJ; Baran RW; Tunis SL
    Curr Med Res Opin; 2009 Jun; 25(6):1343-53. PubMed ID: 19419339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjustment for time-dependent unmeasured confounders in marginal structural Cox models using validation sample data.
    Burne RM; Abrahamowicz M
    Stat Methods Med Res; 2019 Feb; 28(2):357-371. PubMed ID: 28835193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: a retrospective database analysis.
    Lee LJ; Yu AP; Johnson SJ; Birnbaum HG; Atanasov P; Buesching DP; Jackson JA; Davidson JA
    Diabetes Res Clin Pract; 2010 Jan; 87(1):108-16. PubMed ID: 19896233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.